- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5386 - 1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
Patent holdings for IPC class A61K 31/5386
Total number of patents in this class: 1122
10-year publication summary
|
59
|
47
|
49
|
74
|
92
|
82
|
84
|
118
|
208
|
122
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2699 |
21 |
| Boehringer Ingelheim International GmbH | 4485 |
19 |
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
19 |
| Bristol-myers Squibb Company | 4764 |
18 |
| Merck Sharp & Dohme LLC | 3738 |
18 |
| Genentech, Inc. | 4119 |
15 |
| Pfizer Inc. | 3413 |
15 |
| Arvinas Operations, Inc. | 247 |
15 |
| Gilead Sciences, Inc. | 2242 |
14 |
| Repare Therapeutics, Inc. | 60 |
13 |
| Vertex Pharmaceuticals Incorporated | 1575 |
12 |
| Revolution Medicines, Inc. | 336 |
12 |
| Merck Patent GmbH | 5739 |
11 |
| Bayer AG | 3562 |
11 |
| Novartis AG | 10175 |
10 |
| Bayer Pharma AG | 1009 |
10 |
| Amgen Inc. | 4436 |
10 |
| Mirati Therapeutics, Inc. | 288 |
10 |
| Kymera Therapeutics, Inc. | 261 |
10 |
| Janssen Pharmaceutica N.V. | 3160 |
9 |
| Other owners | 850 |